Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NRX Pharmaceuticals Inc
NRXP
Financial Services
Healthcare
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of...
ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:NRXP)
New Post
View:
Posts & Comments
Threaded Posts
(88)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Mar 04, 2024 3:15pm
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, L
BREAKING NEWS: $NRXP NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar DepressionNRx Pharmaceuticals
...more
(88)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 02, 2024 2:00pm
NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance w
News; $NRXP NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS StandardNRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard PR Newswire Company
...more
Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
posted May 03, 2024 9:00am by
Pulsar Helium Inc.
-
|
In recognition of the recent docu-film highlighting the importance of helium in healthcare we are offering investors an opportunity to join Pulsar on the ground in Minnesota for this month's historic reservoir flow tests. CLICK HERE ...read more
(29)
•••
flight100
X
View Profile
View Bullboard History
Post by
flight100
on May 26, 2022 1:42pm
NRXP is rebounding now 0.57
eom
(29)
•••
flight100
X
View Profile
View Bullboard History
Post by
flight100
on May 26, 2022 1:02pm
Buying NRXP at 0.5 It still has $40mil cash in its treasury
As per NRXP financial news, NRXP had $40 million cash as of March 31. So, current price 0.51 is steal and the stock price should move up very quickly. As of March 31, 2022, cash was
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 11, 2021 8:01am
NRXP ...... NR on watch
Do some research
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Oct 19, 2021 8:05am
ALL YOU NEED TO KNOW ABOUT NRX PHARMACEUTICALS!
$NRXP There is a lot of buzz around NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing ZYESAMI™ (AVIPTADIL®) for the treatment of respiratory
...more
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Oct 14, 2021 11:50pm
NRXP - Thursday Rundown, Friday Expectations
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company